相关实验视频
Updated: Jun 14, 2025
11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.4K
癌症中的上皮-半机细胞过渡:关注伊特拉可纳,一种刺抑制剂
Aniruddha Murahar Kulkarni1, Prasanna Kumar Reddy Gayam1, Beena Thazhackavayal Baby1
1Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Udupi, Karnataka 576104, India.
Biochimica et biophysica acta. Reviews on cancer
|February 12, 2025
概括
本综述探讨伊特拉科纳作为一种潜在的药物,可以抑制上皮细胞 - 介质细胞过渡 (EMT),这是癌症转移和死亡的一个关键过程. 重新使用伊特拉科纳可能提供一种新的策略来对抗癌症的进展.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症死亡率与转移性进展有显著联系,由瘤细胞扩散驱动.
- 表皮-介质细胞转变 (EMT) 是一种关键的细胞过程,假设产生转移,为表皮细胞赋予介质细胞表型.
- 癌症中的EMT与恶性瘤增加,耐药性,复发以及癌症干细胞样细胞的出现有关.
研究的目的:
- 审查伊特拉可纳作为一种用于抑制EMT的重定向药物的潜力.
- 检查现有证据并确定有关伊特拉科纳在缓解EMT中的作用的知识差距.
- 探索伊特拉可纳的作用机制,特别是其抑制对刺信号的作用.
主要方法:
- 关于伊特拉科纳和EMT的现有研究的文献综述.
- 分析证据,将伊特拉可纳与抑制"刺"信号通路的相关性.
- 综合目前的研究,以评估伊特拉可纳在癌症转移中的治疗潜力.
主要成果:
- 伊特拉可纳已证明它对刺信号传递具有抑制作用.
- 有证据表明,伊特拉可纳可能具有减弱EMT的有益特性.
- 需要进一步的研究,以充分阐明伊特拉可纳在预防癌症转移中的有效性和机制.
结论:
- 抑制EMT是减少癌症死亡率的有希望的策略.
- 药物重新定位,特别是伊特拉可纳,是开发新型抗转移疗法的可行方法.
- 已知伊特拉可纳与黑信号的相互作用需要进一步调查其抗EMT和抗转移潜力.
相关概念视频
02:33Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
01:35Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K